407 related articles for article (PubMed ID: 23831156)
1. MALDI mass spectrometry in prostate cancer biomarker discovery.
Flatley B; Malone P; Cramer R
Biochim Biophys Acta; 2014 May; 1844(5):940-9. PubMed ID: 23831156
[TBL] [Abstract][Full Text] [Related]
2. Peptide and protein imaging mass spectrometry in cancer research.
McDonnell LA; Corthals GL; Willems SM; van Remoortere A; van Zeijl RJ; Deelder AM
J Proteomics; 2010 Sep; 73(10):1921-44. PubMed ID: 20510389
[TBL] [Abstract][Full Text] [Related]
3. The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.
Wang X; Han J; Hardie DB; Yang J; Borchers CH
J Mass Spectrom; 2016 Jan; 51(1):86-95. PubMed ID: 26757076
[TBL] [Abstract][Full Text] [Related]
4. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
[TBL] [Abstract][Full Text] [Related]
5. Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer.
Semmes OJ; Malik G; Ward M
J Cell Biochem; 2006 Jun; 98(3):496-503. PubMed ID: 16552720
[TBL] [Abstract][Full Text] [Related]
6. Use of matrix-assisted laser desorption/ionisation mass spectrometry in cancer research.
Bateson H; Saleem S; Loadman PM; Sutton CW
J Pharmacol Toxicol Methods; 2011; 64(3):197-206. PubMed ID: 21549846
[TBL] [Abstract][Full Text] [Related]
7. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
[TBL] [Abstract][Full Text] [Related]
8. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.
Tanase CP; Codrici E; Popescu ID; Mihai S; Enciu AM; Necula LG; Preda A; Ismail G; Albulescu R
Oncotarget; 2017 Mar; 8(11):18497-18512. PubMed ID: 28061466
[TBL] [Abstract][Full Text] [Related]
11. MALDI MS profiling of post-DRE urine samples highlights the potential of β-microseminoprotein as a marker for prostatic diseases.
Flatley B; Wilmott KG; Malone P; Cramer R
Prostate; 2014 Jan; 74(1):103-11. PubMed ID: 24115268
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of cancer biomarkers.
Shau H; Chandler GS; Whitelegge JP; Gornbein JA; Faull KF; Chang HR
Brief Funct Genomic Proteomic; 2003 Jul; 2(2):147-58. PubMed ID: 15239937
[TBL] [Abstract][Full Text] [Related]
13. Identification of MALDI Imaging Proteolytic Peptides Using LC-MS/MS-Based Biomarker Discovery Data: A Proof of Concept.
Longuespée R; Ly A; Casadonte R; Schwamborn K; Kazdal D; Zgorzelski C; Bollwein C; Kriegsmann K; Weichert W; Kriegsmann J; Schirmacher P; Fresnais M; Oliveira C; Kriegsmann M
Proteomics Clin Appl; 2019 Jan; 13(1):e1800158. PubMed ID: 30525291
[TBL] [Abstract][Full Text] [Related]
14. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
15. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression.
Malik G; Rojahn E; Ward MD; Gretzer MB; Partin AW; Semmes OJ; Veltri RW
Prostate; 2007 Oct; 67(14):1565-75. PubMed ID: 17705230
[TBL] [Abstract][Full Text] [Related]
16. MALDI-MS Protein Profiling of Chemoresistance in Extracellular Vesicles of Cancer Cells.
Stübiger G; Nairn MD; Abban TK; Openshaw ME; Mancera L; Herzig B; Wuczkowski M; Senfter D; Mader RM
Anal Chem; 2018 Nov; 90(22):13178-13182. PubMed ID: 30383359
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic profiling of prostate cancer by matrix assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry imaging using Matrix Coating Assisted by an Electric Field (MCAEF).
Wang X; Han J; Hardie DB; Yang J; Pan J; Borchers CH
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):755-767. PubMed ID: 28017863
[TBL] [Abstract][Full Text] [Related]
18. Laser ionization mass spectrometry in oral squamous cell carcinoma.
Seema S; Krishnan M; Harith AK; Sahai K; Iyer SR; Arora V; Tripathi RP
J Oral Pathol Med; 2014 Aug; 43(7):471-83. PubMed ID: 24112294
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer diagnosis and characterization with mass spectrometry imaging.
Kurreck A; Vandergrift LA; Fuss TL; Habbel P; Agar NYR; Cheng LL
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):297-305. PubMed ID: 29209003
[TBL] [Abstract][Full Text] [Related]
20. MALDI-TOF MS as evolving cancer diagnostic tool: a review.
Rodrigo MA; Zitka O; Krizkova S; Moulick A; Adam V; Kizek R
J Pharm Biomed Anal; 2014 Jul; 95():245-55. PubMed ID: 24699369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
